ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/DiZPK
C12H23N5O3
285.34 g/mol
Research Reagent

DiZPK

CAS1337883-32-5
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

DiZPK is a photo-reactive amino acid probe containing a diazirine group that can be activated by UV light to form covalent crosslinks with nearby biomolecules. It is primarily used in chemical biology research to study protein-protein interactions and map proximity labeling in living cells.

Photo-crosslinking to capture transient protein interactionsProbe for studying protein-protein interactions in chemical biologyTool for proximity labeling in living cells

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing DiZPK?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

Tert-Butyl 4-(4-hydroxy-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)piperidine-1-carboxylate

CAS1337918-85-0

research compound

ReferenceSame Category

(6-bromopyridin-2-yl)(1-methylpiperidin-4-yl)methanone hydrobromide

CAS1338000-32-0

research compound

ReferenceSame Category

1,2-dicervonoylglycerol

CAS133831-25-1

research compound

ReferenceSame Category

1,2,3,4-Tetrahydro-1,5-naphthyridine hydrochloride

CAS1338707-93-9

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-amino-6-[3-(3-methyldiazirin-3-yl)propylcarbamoylamino]hexanoic acid

InChIKey

YGUIFRMUMYTGAV-VIFPVBQESA-N

SMILES

CC1(N=N1)CCCNC(=O)NCCCC[C@@H](C(=O)O)N

Synonyms (6)
  • DiZPK

Sourcing DiZPK?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→